GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JinZangHuang Tibet Pharmaceuticals Inc (OTCPK:JZHG) » Definitions » EV-to-Revenue

JinZangHuang Tibet Pharmaceuticals (JinZangHuang Tibet Pharmaceuticals) EV-to-Revenue : 0.04 (As of May. 07, 2024)


View and export this data going back to . Start your Free Trial

What is JinZangHuang Tibet Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, JinZangHuang Tibet Pharmaceuticals's enterprise value is $0.51 Mil. JinZangHuang Tibet Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2013 was $14.36 Mil. Therefore, JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue for today is 0.04.

The historical rank and industry rank for JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

JZHG's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.37
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-07), JinZangHuang Tibet Pharmaceuticals's stock price is $0.0012. JinZangHuang Tibet Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2013 was $0.30. Therefore, JinZangHuang Tibet Pharmaceuticals's PS Ratio for today is 0.00.


JinZangHuang Tibet Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JinZangHuang Tibet Pharmaceuticals EV-to-Revenue Chart

JinZangHuang Tibet Pharmaceuticals Annual Data
Trend May07 May08 Jun09 Jun10 Jun11 Jun12
EV-to-Revenue
Get a 7-Day Free Trial - 8.90 63.82 4.78 -

JinZangHuang Tibet Pharmaceuticals Quarterly Data
May08 Aug08 Nov08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.33

Competitive Comparison of JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - General subindustry, JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue falls into.



JinZangHuang Tibet Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.510/14.358
=0.04

JinZangHuang Tibet Pharmaceuticals's current Enterprise Value is $0.51 Mil.
JinZangHuang Tibet Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JinZangHuang Tibet Pharmaceuticals  (OTCPK:JZHG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

JinZangHuang Tibet Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0012/0.301
=0.00

JinZangHuang Tibet Pharmaceuticals's share price for today is $0.0012.
JinZangHuang Tibet Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JinZangHuang Tibet Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of JinZangHuang Tibet Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


JinZangHuang Tibet Pharmaceuticals (JinZangHuang Tibet Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
Website
JinZangHuang Tibet Pharmaceuticals Inc is engaged in the distribution of Tibetan pharmaceutical and nutraceutical products in The People's Republic of China.
Executives
Michael Anthony other: Former officer: dir and 10% 330 CLEMATIS STREET SUITE 217 WEST PALM BEACH CA 33401

JinZangHuang Tibet Pharmaceuticals (JinZangHuang Tibet Pharmaceuticals) Headlines

No Headlines